Franciane Paul
10Patents
6h-index
9Co-inventors
55Inventor score
Filing activity: Jan 17, 2013 → Apr 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10640542B2 | Fusokines involving cytokines with strongly reduced receptor binding affinities | Chemistry; Metallurgy | 17 | Active |
| US9732135B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 16 | Active |
| US9878014B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 14 | Active |
| US9492562B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 14 | Active |
| US10072059B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 13 | Active |
| US10034919B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 13 | Active |
| US10946070B2 | Targeted and mutated human-interferon fusion proteins | Chemistry; Metallurgy | 3 | Active |
| US10947288B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 3 | Active |
| US11358997B2 | Fusokines involving cytokines with strongly reduced receptor binding affinities | Chemistry; Metallurgy | 1 | Active |
| US12410222B2 | Fusokines involving cytokines with strongly reduced receptor binding affinities | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.